Sign In
Buy MNPR
$60.56
-0.700 (-1.14%)
At Close: Jun 03, 2026
Monopar Therapeutics : Reports Fourth Quarter and Full-Year 2019 Financial Results and Business Updates | MarketScreener
12:15pm, Friday, 27'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
MONOPAR THERAPEUTICS : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | MarketScreener
02:05pm, Tuesday, 18'th Feb 2020
Monopar Therapeutics Inc. (MNPR) today announced it has been granted Orphan Drug Designation from the European Commission for its drug candidate camsirubicin in the treatment of soft tissue sarcoma (S
Monopar Therapeutics Inc (MNPR) Initiated with a Buy at JonesTrading
01:18pm, Monday, 03'rd Feb 2020
In a report released today, Soumit Roy from JonesTrading initiated coverage with a Buy rating on Monopar Therapeutics Inc (MNPR) and a price target of
Monopar Therapeutics Inc (MNPR) Initiated with a Buy at JonesTrading
01:18pm, Monday, 03'rd Feb 2020
In a report released today, Soumit Roy from JonesTrading initiated coverage with a Buy rating on Monopar Therapeutics Inc (MNPR
9 Up-and-Coming Small-Cap Stocks to Watch
05:06pm, Tuesday, 14'th Jan 2020
With large-capitalization firms looking stretched in this long-in-the-tooth bull market, here are the small-cap stocks to watch instead.
Monopar Therapeutics Inc. Announces Closing of Initial Public Offering of Common Stock
05:30pm, Monday, 23'rd Dec 2019
Monopar Therapeutics Inc. today announced the closing of its initial public offering of 1,277,778 shares of common stock, including the underwriters’ exercise of its over-allotment option, at a publ
Monopar Therapeutics Inc. Announces Full Exercise of Over-Allotment by Underwriters
09:46pm, Friday, 20'th Dec 2019
Monopar Therapeutics Inc. today announced that the underwriters of its previously announced initial public offering of common stock have exercised in full their option to purchase an additional 166,66
Monopar Therapeutics Inc. Announces Pricing of Initial Public Offering
12:53am, Thursday, 19'th Dec 2019
Monopar Therapeutics Inc. today announced that it has priced an initial public offering of 1,111,112 shares of its common stock at $8.00 per share. The shares are expected to begin trading on the Nas
Xconomy: Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street
04:01pm, Thursday, 03'rd Oct 2019
With five biotech IPOs on the calendar, this week was expected to be a big one. Three companies ended up making Wall Street debuts, raising a combined
The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo
11:34am, Thursday, 03'rd Oct 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 2) Dova Pharmaceuticals Inc (NASDAQ: DOVA ) Down In The
